Bionano Genomics, Inc.

BMV:BNGO * Stock Report

Market Cap: Mex$888.1m

Bionano Genomics Management

Management criteria checks 3/4

Bionano Genomics' CEO ist Robert Holmlin , ernannt in Jan 2011, hat eine Amtszeit von 13.08 Jahren. Die jährliche Gesamtvergütung beträgt $2.77M , bestehend aus 19.7% Gehalt und 80.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.13% der Aktien des Unternehmens, im Wert von MX$1.04M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.1 Jahre bzw. 4.8 Jahre.

Key information

Robert Holmlin

Chief executive officer

US$2.8m

Total compensation

CEO salary percentage19.7%
CEO tenure13.3yrs
CEO ownership0.1%
Management average tenure2.3yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Robert Holmlin's remuneration changed compared to Bionano Genomics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$232m

Sep 30 2023n/an/a

-US$227m

Jun 30 2023n/an/a

-US$147m

Mar 31 2023n/an/a

-US$140m

Dec 31 2022US$3mUS$544k

-US$133m

Sep 30 2022n/an/a

-US$117m

Jun 30 2022n/an/a

-US$106m

Mar 31 2022n/an/a

-US$92m

Dec 31 2021US$8mUS$484k

-US$72m

Sep 30 2021n/an/a

-US$61m

Jun 30 2021n/an/a

-US$51m

Mar 31 2021n/an/a

-US$41m

Dec 31 2020US$708kUS$376k

-US$41m

Sep 30 2020n/an/a

-US$37m

Jun 30 2020n/an/a

-US$33m

Mar 31 2020n/an/a

-US$32m

Dec 31 2019US$899kUS$404k

-US$30m

Sep 30 2019n/an/a

-US$28m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$3mUS$390k

-US$18m

Sep 30 2018n/an/a

-US$18m

Jun 30 2018n/an/a

-US$18m

Mar 31 2018n/an/a

-US$22m

Dec 31 2017US$605kUS$379k

-US$23m

Vergütung im Vergleich zum Markt: RobertDie Gesamtvergütung ($USD2.77M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt MX ($USD214.14K).

Entschädigung vs. Einkommen: RobertDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


CEO

Robert Holmlin (55 yo)

13.3yrs

Tenure

US$2,766,572

Compensation

Dr. Robert Erik Holmlin, Ph D., M.B.A. has been the Chief Executive Officer and President of BioNano Genomics, Inc. (alternatively BioNanomatrix, Inc.) since January 12, 2011 and serves as its Secretary. D...


Leadership Team

NamePositionTenureCompensationOwnership
Robert Holmlin
President13.3yrsUS$2.77m0.12%
$ 1.0m
Mark Oldakowski
Chief Operating Officer6.4yrsUS$1.50m0.074%
$ 660.0k
Alka Chaubey
Chief Medical Officer3.7yrsUS$1.32m0.058%
$ 511.3k
Gulsen Kama
Chief Financial Officerless than a yearno datano data
Mark Adamchak
VP of Accounting & Controller5.8yrsno datano data
Jonathan Dixon
General Counsel2.3yrsno data0.0064%
$ 57.2k
Stanislas Marin
Vice President of Global Sales2.3yrsno datano data
Donna Polizio
Global Head of Market Access1.4yrsno datano data
Cory Kreeck
Global Head of People Operations2.3yrsno datano data
Klint Rose
Head of Research & Developmentless than a yearno datano data

2.3yrs

Average Tenure

49.5yo

Average Age

Erfahrenes Management: BNGO *Das Führungsteam des Unternehmens gilt als erfahren (2 Jahre durchschnittliche Betriebszugehörigkeit).


Board Members

NamePositionTenureCompensationOwnership
Robert Holmlin
President13.3yrsUS$2.77m0.12%
$ 1.0m
Christopher Twomey
Independent Director5.8yrsUS$224.42k0.012%
$ 104.7k
David Barker
Independent Chairman of the Board13.9yrsUS$249.42k0.011%
$ 94.8k
Albert Luderer
Independent Director12.5yrsUS$229.42k0%
$ 0
Hannah Mamuszka
Independent Director3.9yrsUS$211.92k0.012%
$ 106.8k
Kristiina Vuori
Independent Director4.9yrsUS$221.92k0%
$ 0
Yvonne Linney
Independent Director3.9yrsUS$209.42k0%
$ 0
Vincent Wong
Independent Director2.3yrsUS$214.42k0%
$ 0
Aleksandar Rajkovic
Independent Director2.2yrsUS$451.18k0%
$ 0

4.9yrs

Average Tenure

58yo

Average Age

Erfahrener Vorstand: BNGO *Die Vorstandsmitglieder gelten als erfahren (4.6 Jahre durchschnittliche Amtszeit).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.